The 2020 WHO Classification of Tumors of Bone: An Updated Review

被引:235
作者
Choi, Joon Hyuk [1 ]
Ro, Jae Y. [2 ]
机构
[1] Yeungnam Univ, Dept Pathol, Coll Med, 170 Hyeonchung Ro, Daegu 42415, South Korea
[2] Cornell Univ, Houston Methodist Hosp, Weill Med Coll, Dept Pathol & Genom Med, Houston, TX USA
关键词
WHO classification; bone; tumor; sarcoma; genetics; GIANT-CELL TUMOR; POORLY DIFFERENTIATED CHORDOMA; GENETICALLY-DISTINCT-VARIANT; INTERNAL TANDEM DUPLICATION; CIC-REARRANGED SARCOMAS; ROSAI-DORFMAN DISEASE; DEDIFFERENTIATED CHONDROSARCOMA; EPITHELIOID HEMANGIOENDOTHELIOMA; SOFT-TISSUE; FIBROCARTILAGINOUS MESENCHYMOMA;
D O I
10.1097/PAP.0000000000000293
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Bone tumors are a rare and heterogeneous group of neoplasms that occur in the bone. The diversity and considerable morphologic overlap of bone tumors with other mesenchymal and nonmesenchymal bone lesions can complicate diagnosis. Accurate histologic diagnosis is crucial for appropriate management and prognostication. Since the publication of the fourth edition of the World Health Organization (WHO) classification of tumors of soft tissue and bone in 2013, significant advances have been made in our understanding of bone tumor molecular biology, classification, prognostication, and treatment. Detection of tumor-specific molecular alterations can facilitate the accurate diagnosis of histologically challenging cases. The fifth edition of the 2020 WHO classification of tumors of soft tissue and bone tumors provides an updated classification scheme and essential diagnostic criteria for bone tumors. Herein, we summarize these updates, focusing on major changes in each category of bone tumor, the newly described tumor entities and subtypes of existing tumor types, and newly described molecular and genetic data.
引用
收藏
页码:119 / 138
页数:20
相关论文
共 229 条
[11]   H3F3A (Histone 3.3) G34W Immunohistochemistry: A Reliable Marker Defining Benign and Malignant Giant Cell Tumor of Bone [J].
Amary, Fernanda ;
Berisha, Fitim ;
Ye, Hongtao ;
Gupta, Manu ;
Gutteridge, Alice ;
Baumhoer, Daniel ;
Gibbons, Rebecca ;
Tirabosco, Roberto ;
O'Donnell, Paul ;
Flanagan, Adrienne M. .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2017, 41 (08) :1059-1068
[12]   Isocitrate dehydrogenase 1 mutations (IDH1) and p16/CDKN2A copy number change in conventional chondrosarcomas [J].
Amary, M. Fernanda ;
Ye, Hongtao ;
Forbes, Georgina ;
Damato, Stephen ;
Maggiani, Francesca ;
Pollock, Robin ;
Tirabosco, Roberto ;
Flanagan, Adrienne M. .
VIRCHOWS ARCHIV, 2015, 466 (02) :217-222
[13]   Ollier disease and Maffucci syndrome are caused by somatic mosaic mutations of IDH1 and IDH2 [J].
Amary, M. Fernanda ;
Damato, Stephen ;
Halai, Dina ;
Eskandarpour, Malihe ;
Berisha, Fitim ;
Bonar, Fiona ;
McCarthy, Stan ;
Fantin, Valeria R. ;
Straley, Kimberly S. ;
Lobo, Samira ;
Aston, Will ;
Green, Claire L. ;
Gale, Rosemary E. ;
Tirabosco, Roberto ;
Futreal, Andrew ;
Campbell, Peter ;
Presneau, Nadege ;
Flanagan, Adrienne M. .
NATURE GENETICS, 2011, 43 (12) :1262-U129
[14]   IDH1 and IDH2 mutations are frequent events in central chondrosarcoma and central and periosteal chondromas but not in other mesenchymal tumours [J].
Amary, M. Fernanda ;
Bacsi, Krisztian ;
Maggiani, Francesca ;
Damato, Stephen ;
Halai, Dina ;
Berisha, Fitim ;
Pollock, Robin ;
O'Donnell, Paul ;
Grigoriadis, Anita ;
Diss, Tim ;
Eskandarpour, Malihe ;
Presneau, Nadege ;
Hogendoorn, Pancras C. W. ;
Futreal, Andrew ;
Tirabosco, Roberto ;
Flanagan, Adrienne M. .
JOURNAL OF PATHOLOGY, 2011, 224 (03) :334-343
[15]   Population-based study of giant cell tumor of bone in Sweden (1983-2011) [J].
Amelio, Justyna M. ;
Rockberg, Julia ;
Hernandez, Rohini K. ;
Sobocki, Patrik ;
Stryker, Scott ;
Bach, Bruce A. ;
Engellau, Jacob ;
Liede, Alexander .
CANCER EPIDEMIOLOGY, 2016, 42 :82-89
[16]  
Anderson T, 2015, AM J SURG PATHOL, V39, P132, DOI 10.1097/PAS.0000000000000346
[17]   Clinical outcome of central conventional chondrosarcoma [J].
Angelini, Andrea ;
Guerra, Giovanni ;
Mavrogenis, Andreas F. ;
Pala, Elisa ;
Picci, Piero ;
Ruggieri, Pietro .
JOURNAL OF SURGICAL ONCOLOGY, 2012, 106 (08) :929-937
[18]  
[Anonymous], 2010, Dahlin's bone tumors
[19]  
[Anonymous], 2020, WHO CLASSIFICATION T, V3
[20]  
Antonescu C.R., 2020, WHO CLASSIFICATION T, P333